In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

X-BODY Inc.

Division of Celgene Corp.
www.x-bodybiosciences.com

Latest From X-BODY Inc.

Early-Stage Investments Propel Jump In Life Sciences Venture Capital

In some cases, early venture capital appears to be substituting for the public market in providing finance not only to start but also sustain companies in specialty pharma and in-licensing, development-only businesses. At least 200 capital groups took part in the 156 recorded A rounds, and 50 participated in more than one.

United States Business Strategies

Early-Stage Investments Propel Jump In Life Sciences Venture Capital

In some cases, early venture capital appears to be substituting for the public market in providing finance not only to start but also sustain companies in specialty pharma and in-licensing, development-only businesses. At least 200 capital groups took part in the 156 recorded A rounds, and 50 participated in more than one.

United States Business Strategies

The A-List: The Trend-Shaping Series A Financings Of 2015

Our 12th annual analysis reveals both an expansion of historical patterns of Series A financings and the emergence of a new group of heavily committed, relatively short-term investors.

BioPharmaceutical Medical Device

Start-Up Quarterly Statistics, Q2 2015

Life sciences start-ups raised $2.61 billion in Q2 2015. Biotechs penned 38 alliances; seven acquisitions were signed, none in the medical device industry.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • X-Body Biosciences Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Celgene Corp.
  • Senior Management
  • Yan Chen, MD, PhD, SVP, Research
  • Contact Info
  • X-BODY Inc.
    Phone: (781) 419-6990
    100 Beaver St.
    Ste. 101
    Waltham, MA 02453
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register